[
  {
    "ts": null,
    "headline": "Denali: Despite ALS Primary Endpoint Failure, Possible Path Forward Remains",
    "summary": "Denali Therapeutics Inc.'s stock remains stable despite trial setback in ALS. BLA filing for MPS II treatment on track. Click for my DNLI stock update.",
    "url": "https://finnhub.io/api/news?id=b6865f1c4ce4f4925e66575258010aae3f2a62cf25ed46e91fe3c59b242b8b7c",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736438203,
      "headline": "Denali: Despite ALS Primary Endpoint Failure, Possible Path Forward Remains",
      "id": 132352308,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2176382509/image_2176382509.jpg?io=getty-c-w1536",
      "related": "BIIB",
      "source": "SeekingAlpha",
      "summary": "Denali Therapeutics Inc.'s stock remains stable despite trial setback in ALS. BLA filing for MPS II treatment on track. Click for my DNLI stock update.",
      "url": "https://finnhub.io/api/news?id=b6865f1c4ce4f4925e66575258010aae3f2a62cf25ed46e91fe3c59b242b8b7c"
    }
  },
  {
    "ts": null,
    "headline": "ClearBridge Growth Strategy Q4 2024 Commentary",
    "summary": "The ClearBridge Growth Strategy underperformed its Russell Midcap Growth Index benchmark in the fourth quarter. Click here to read the full commentary.",
    "url": "https://finnhub.io/api/news?id=a062d5834c0cc6d55153a6cdeb3395c34fbd59bc73b0c15d504a33195b56b2c5",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736421300,
      "headline": "ClearBridge Growth Strategy Q4 2024 Commentary",
      "id": 132348792,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1385299427/image_1385299427.jpg?io=getty-c-w1536",
      "related": "BIIB",
      "source": "SeekingAlpha",
      "summary": "The ClearBridge Growth Strategy underperformed its Russell Midcap Growth Index benchmark in the fourth quarter. Click here to read the full commentary.",
      "url": "https://finnhub.io/api/news?id=a062d5834c0cc6d55153a6cdeb3395c34fbd59bc73b0c15d504a33195b56b2c5"
    }
  },
  {
    "ts": null,
    "headline": "Biogen : Appoints Adam Feire as Head of Business Development and External Innovation",
    "summary": "today announced the appointment of Adam Feire, Ph.D., as Head of Business Development and External Innovation. Mr. Feire reports to Adam Keeney, Ph.D., Executive Vice President and Head of Corporate...",
    "url": "https://finnhub.io/api/news?id=d8057b4d95051a850cb586479878f561e3f500ed52d00e463644c4c8c2665763",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736408412,
      "headline": "Biogen : Appoints Adam Feire as Head of Business Development and External Innovation",
      "id": 132346800,
      "image": "",
      "related": "BIIB",
      "source": "Finnhub",
      "summary": "today announced the appointment of Adam Feire, Ph.D., as Head of Business Development and External Innovation. Mr. Feire reports to Adam Keeney, Ph.D., Executive Vice President and Head of Corporate...",
      "url": "https://finnhub.io/api/news?id=d8057b4d95051a850cb586479878f561e3f500ed52d00e463644c4c8c2665763"
    }
  }
]